[{"orgOrder":0,"company":"Sanzyme","sponsor":"J.B.Chemicals & Pharmaceuticals","pharmaFlowCategory":"D","therapeuticArea":"Gastroenterology","country":"","productType":"Large molecule","year":"2022","type":"Acquisition","leadProduct":"Lacticacid Bacillus","moa":"","graph1":"Gastroenterology","graph2":"Approved","graph3":"Sanzyme","amount2":0.080000000000000002,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Gastroenterology","amount2New":0.080000000000000002,"dosageForm":"Tablet","sponsorNew":"Sanzyme \/ JB Chemicals","highestDevelopmentStatusID":"12","companyTruncated":"Sanzyme \/ JB Chemicals"},{"orgOrder":0,"company":"Sanzyme","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"","productType":"Large molecule","year":"2022","type":"Not Applicable","leadProduct":"Probiotic Strain SNZ 1969","moa":"","graph1":"Gastroenterology","graph2":"Approved","graph3":"Sanzyme","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Sanzyme \/ Not Applicable","highestDevelopmentStatusID":"12","companyTruncated":"Sanzyme \/ Not Applicable"}]

Find Clinical Drug Pipeline Developments & Deals by Sanzyme

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Pharmtech & Ingredients
                          Not Confirmed
                          Pharmtech & Ingredients
                          Not Confirmed

                          Details : Latest study shows Sanzyme Biologics's Bacillus coagulans SNZ 1969® (Weizmannia coagulans SNZ 1969), a natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in managing IBS...

                          Brand Name : SNZ 1969

                          Molecule Type : Large molecule

                          Upfront Cash : Not Applicable

                          November 29, 2022

                          Lead Product(s) : Probiotic Strain SNZ 1969

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Approved

                          Sponsor : Not Applicable

                          Deal Size : Not Applicable

                          Deal Type : Not Applicable

                          blank

                          02

                          Pharmtech & Ingredients
                          Not Confirmed
                          Pharmtech & Ingredients
                          Not Confirmed

                          Details : The probiotic portfolio includes Sporlac, which is the third-largest probiotics brand in India, and specialised products like Lobun used for delaying progression of chronic kidney disease and Oxalo, an alternate risk-free therapy to decalcify kidney ston...

                          Brand Name : Sporlac

                          Molecule Type : Large molecule

                          Upfront Cash : Undisclosed

                          January 26, 2022

                          Lead Product(s) : Lacticacid Bacillus

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Approved

                          Sponsor : J.B.Chemicals & Pharmaceuticals

                          Deal Size : $84.0 million

                          Deal Type : Acquisition

                          blank